Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The "letter", then the "financials" and now..the "burn" ; -)
View:
Post by SouthernTierTom on Apr 29, 2021 7:18pm

The "letter", then the "financials" and now..the "burn" ; -)

Sounds like the ordeal I went through when I used to "dance", put me through college, don't ask : - )

Yeah, I got a letter from public health, the club asked me not to be there for awhile and then it was home sweet home with a long and painful bout of the "burn"

I don't know bout you fellas, but this hard luck 23 center looks like a tough hold right now ; - (

I thought maybe the 11 cancer centers and in particular that highly regarded Princess Margaret site would allow for sum appreciation....heck add that FDA FAST-TRACK with little to now fan-fare and you have yourself another STD scenario...

I'm hanging on and looking for places to add, too much candy here and like the "burn", eventually it went away and I got back on my business...so to speak ; - )

NOBODY is gonna tell me this ain't the best little bio this side of the Missississississippi

Bon chance fellas!

Tommy two-step ; - )
Comment by inspecthrgadget on Apr 30, 2021 9:31am
I recognize the "threesome" This bullboard is as good a guide to movement as Ive seen. Any astute reader knows Tommy called the last money raise when all the band members churned and burned the naive in the 55 cent range. You Tommy are an absolute breath of fresh air here. Thanks for recognizing a clear and far too obvious bullboard program. You my friend are exactly what retailers ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250